1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Pfizer Global Medical Grants: Antimicrobial Stewardship and AMR is a competitive grant program from Pfizer Inc. that funds independent initiatives — including research, quality improvement, and education — aimed at improving patient outcomes in antimicrobial stewardship and combating antimicrobial resistance (AMR).
Pfizer publishes Requests for Proposals (RFPs) outlining specific gaps in research, practice, or care, and invites organizations to apply. Grantees are responsible for the design, implementation, and conduct of their initiatives. Eligible applicants include medical centers, universities, and healthcare organizations globally.
Awards typically range from $50,000 to $250,000. Applications are reviewed on a rolling RFP basis — check Pfizer's grants portal for current open solicitations.
Get alerted about grants like this
Save a search for “Pfizer Inc.” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Competitive Grants Program | Pfizer Clinical Trials in Children Integrity and Transparency Plain Language Study Results Expanded Access & Compassionate Use Inflammation & Immunology PfizerPro for Professionals Patient Assistance Programs Behind the Science Features Patient Advocacy & Engagement Diversity, Equity, and Inclusion Environmental Sustainability Stem Cell Research Policy Working with Healthcare Professionals Prescription Value & Pricing Corporate Governance Overview Board Committees & Charters The Pfizer Board Policies Corporate Governance FAQs Research and Business Development Partnerships Submit Your Opportunities Suggestions within Pfizer.
com Competitive Grants Program Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.
The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Independent Medical Education Investigator Sponsored Research Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Shared Decision Making in Hemophilia Patient Care Release Date: December 11, 2025 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Rare Disease China March 12, 2026 Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC) Release Date: January 8, 2026 Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Oncology Canada March 17, 2026 Optimizing HRRm Testing and Workflow Integration in mCSPC Release Date: January 12, 2026 Review Process: Expert Review Panel View RFP (PDF) Quality Improvement, Research Oncology Canada April 8, 2026 Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in China Release Date: January 15, 2026 Review Process: Pfizer Internal View RFP (PDF) Research Inflammation & Immunology China March 31, 2026 Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource Utilizatio Release Date: January 15, 2026 Review Process: Pfizer Internal View RFP (PDF) Research Inflammation & Immunology China March 31, 2026 Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across Canada Release Date: January 15, 2026 Partner: Colorectal Cancer Canada (CCC) Review Process: Expert Review Panel View RFP (PDF) Quality Improvement, Research Oncology Canada April 15, 2026 Optimizing Disease Management to Improve Alopecia Areata Quality of Care Release Date: January 15, 2026 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Inflammation & Immunology China April 30, 2026 Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for Vitiligo Release Date: January 16, 2026 Review Process: Pfizer Internal View RFP (PDF) Research Inflammation & Immunology China March 19, 2026 Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC) Release Date: January 26, 2026 Partner: American Society for Clinical Pathology (ASCP) Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Oncology USA March 31, 2026 Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factors Release Date: January 26, 2026 Review Process: Expert Review Panel View RFP (PDF) Quality Improvement, Research Oncology Italy March 27, 2026 Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Pneumococcal Disease Prevention Release Date: April 11, 2012 Review Process: View RFP (PDF) Release Date: May 8, 2012 Review Process: View RFP (PDF) Release Date: June 28, 2012 Review Process: View RFP (PDF) Pharmacy Pneumococcal Disease Prevention Release Date: June 28, 2012 Review Process: View RFP (PDF) Release Date: July 2, 2012 Review Process: View RFP (PDF) Non-Small Cell Lung Cancer Release Date: July 10, 2012 Review Process: View RFP (PDF) Cardiovascular Risk in Rheumatoid Arthritis Release Date: July 25, 2012 Review Process: View RFP (PDF) Release Date: July 26, 2012 Review Process: View RFP (PDF) Adult Pneumococcal Disease Prevention Release Date: August 29, 2012 Review Process: View RFP (PDF) Prevention of Stroke in Women Release Date: September 13, 2012 Review Process: View RFP (PDF) Oncology Educational Needs Assessments Release Date: October 22, 2012 Review Process: View RFP (PDF) Release Date: November 1, 2012 Review Process: View RFP (PDF) This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.
Based on current listing details, eligibility includes: Medical centers, universities, and healthcare organizations. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $50,000 - $250,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.